Literature DB >> 2012517

Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals.

R Schmidt1, F Fazekas, H Offenbacher, H Lytwyn, B Blematl, K Niederkorn, S Horner, F Payer, W Freidl.   

Abstract

To search for a morphologic basis of cognitive impairment possibly associated with essential hypertension, we studied 35 otherwise asymptomatic hypertensive individuals (mean age, 38.7 years; range, 22 to 49 years) and 20 normotensive control subjects (mean age, 37.9 years; range, 26 to 49 years) using neuropsychologic tests and magnetic resonance imaging. Irrespective of drug treatment, hypertensive individuals performed significantly worse than did control subjects when assessed for verbal memory and total learning and memory capacity, while there were no differences in test results of visual memory, attention, vigilance, and reaction time. The hypertensive individuals also described themselves as less active but ranked similar on five other mood subscales. Punctate high-signal intensities of the white matter were found almost twice as often in the hypertensive group (38%) as in the control group (20%). There was no difference in test performance between hypertensive individuals with and those without white matter lesions, however. Our results confirm the presence of subtle neuropsychologic deficits and indicate a higher frequency of white matter signal abnormalities in essential hypertension, as shown on magnetic resonance imaging, but do not indicate a correlation of these findings with each other.

Entities:  

Mesh:

Year:  1991        PMID: 2012517     DOI: 10.1001/archneur.1991.00530160087019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

1.  Chronic, severe hypertension does not impair spatial learning and memory in Sprague-Dawley rats.

Authors:  I Kadish; T van Groen; J M Wyss
Journal:  Learn Mem       Date:  2001 Mar-Apr       Impact factor: 2.460

2.  Is the whole brain periventricular?

Authors:  F Barkhof; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

3.  Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  John Gunstad; Ronald A Cohen; David F Tate; Robert H Paul; Athena Poppas; Karin Hoth; Kristin L Macgregor; Angela L Jefferson
Journal:  Blood Press       Date:  2005       Impact factor: 2.835

4.  Carotid artery wall thickness and leukoaraiosis: preliminary results using multidetector row CT angiography.

Authors:  L Saba; L Pascalis; R Sanfilippo; M Anzidei; R Bura; R Montisci; G Mallarini
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 5.  Cerebral white matter lesions in essential hypertension.

Authors:  C Sierra
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 6.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Effect of white matter disease on functional connections in the aging brain.

Authors:  A F Leuchter; J J Dunkin; R B Lufkin; Y Anzai; I A Cook; T F Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  The effects of type 1 diabetes on cerebral white matter.

Authors:  K Weinger; A M Jacobson; G Musen; I K Lyoo; C M Ryan; D C Jimerson; P F Renshaw
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

9.  Hypertension and mild cognitive impairment.

Authors:  Cristina Sierra; Mónica Doménech; Miguel Camafort; Antonio Coca
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

10.  Magnetic resonance imaging after most common form of concussion.

Authors:  Harald Schrader; Dalia Mickeviciene; Rymante Gleizniene; Silvija Jakstiene; Danguole Surkiene; Lars Jacob Stovner; Diana Obelieniene
Journal:  BMC Med Imaging       Date:  2009-06-17       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.